Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease.

Hodgson R, Reason T, Trueman D, Wickstead R, Kusel J, Jasilek A, Claxton L, Taylor M, Pulikottil-Jacob R.

Adv Ther. 2017 Oct;34(10):2360-2370. doi: 10.1007/s12325-017-0620-x. Epub 2017 Oct 10.


Interactive web-based pulmonary rehabilitation programme: a randomised controlled feasibility trial.

Chaplin E, Hewitt S, Apps L, Bankart J, Pulikottil-Jacob R, Boyce S, Morgan M, Williams J, Singh S.

BMJ Open. 2017 Mar 31;7(3):e013682. doi: 10.1136/bmjopen-2016-013682.


The Community In-reach Rehabilitation and Care Transition (CIRACT) clinical and cost-effectiveness randomisation controlled trial in older people admitted to hospital as an acute medical emergency.

Sahota O, Pulikottil-Jacob R, Marshall F, Montgomery A, Tan W, Sach T, Logan P, Kendrick D, Watson A, Walker M, Waring J.

Age Ageing. 2017 Jan 6;46(1):26-32. doi: 10.1093/ageing/afw149.


Has Metal-On-Metal Resurfacing Been a Cost-Effective Intervention for Health Care Providers?-A Registry Based Study.

Pulikottil-Jacob R, Connock M, Kandala NB, Mistry H, Grove A, Freeman K, Costa M, Sutcliffe P, Clarke A.

PLoS One. 2016 Nov 1;11(11):e0165021. doi: 10.1371/journal.pone.0165021. eCollection 2016.


Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom.

Claxton L, Hodgson R, Taylor M, Malcolm B, Pulikottil Jacob R.

Pharmacoeconomics. 2017 Feb;35(2):237-248. doi: 10.1007/s40273-016-0459-z.


The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK.

Ghosh W, Wickstead R, Claxton L, Kusel J, Taylor M, Fleetwood K, Pulikottil-Jacob R.

Adv Ther. 2016 Sep;33(9):1660-76. doi: 10.1007/s12325-016-0367-9. Epub 2016 Jul 25.


A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study.

Bowrey DJ, Baker M, Halliday V, Thomas AL, Pulikottil-Jacob R, Smith K, Morris T, Ring A.

Trials. 2015 Nov 21;16:531. doi: 10.1186/s13063-015-1053-y.


Setting benchmark revision rates for total hip replacement: analysis of registry evidence.

Kandala NB, Connock M, Pulikottil-Jacob R, Sutcliffe P, Crowther MJ, Grove A, Mistry H, Clarke A.

BMJ. 2015 Mar 9;350:h756. doi: 10.1136/bmj.h756.


Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.

Clarke A, Pulikottil-Jacob R, Grove A, Freeman K, Mistry H, Tsertsvadze A, Connock M, Court R, Kandala NB, Costa M, Suri G, Metcalfe D, Crowther M, Morrow S, Johnson S, Sutcliffe P.

Health Technol Assess. 2015 Jan;19(10):1-668, vii-viii. doi: 10.3310/hta19100. Review.


Understanding why children die in high-income countries.

Sidebotham P, Fraser J, Covington T, Freemantle J, Petrou S, Pulikottil-Jacob R, Cutler T, Ellis C.

Lancet. 2014 Sep 6;384(9946):915-27. doi: 10.1016/S0140-6736(14)60581-X. Review.


Six weeks of home enteral nutrition versus standard care after esophagectomy or total gastrectomy for cancer: study protocol for a randomized controlled trial.

Bowrey DJ, Baker M, Halliday V, Thomas AL, Pulikottil-Jacob R, Smith K.

Trials. 2014 May 24;15:187. doi: 10.1186/1745-6215-15-187.


Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.

Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, Banner NR, Clarke A.

J Heart Lung Transplant. 2014 Apr;33(4):350-8. doi: 10.1016/j.healun.2014.01.003. Epub 2014 Jan 19.


Response to two recent BMJ papers on mortality after hip replacement: comparative modelling study.

Kandala NB, Connock M, Pulikottil-Jacob R, Mistry H, Sutcliffe P, Costa M, Clarke A.

BMJ. 2014 Feb 19;348:g1506. doi: 10.1136/bmj.g1506. No abstract available.


Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program.

Clarke A, Pulikottil-Jacob R, Connock M, Suri G, Kandala NB, Maheswaran H, Banner NR, Sutcliffe P.

Int J Cardiol. 2014 Feb 15;171(3):338-45. doi: 10.1016/j.ijcard.2013.12.015. Epub 2013 Dec 18.

Supplemental Content

Loading ...
Support Center